Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Bharat Immunological & Biologicals Corporation Ltd

NSE: BIBCL · BSE: 524663 · Pharmaceuticals & Biotechnology · 1 announcements

Share price
₹9.10
Market cap
₹39.29 Cr
Revenue (annual)
₹44.61 Cr
Net profit (annual)
₹-17.06 Cr
P/E (TTM)
-2.1×Sector 47.3×
Promoter holding
59.25%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

11:44 IST BSE
Merger & Restructuring

Bharat Immunological & Biologicals Corporation Merger & Restructuring

GOI has approved the closure/winding-up of BIBCOL. This Reg 30 disclosure signals the company's eventual delisting and wind-down of operations.